Laura R. Bohrer
Papers
2
Total Citations
40
H-Index
2
About
Dr. Laura R. Bohrer is pioneering the automation of regenerative medicine, with a sharp focus on using human induced pluripotent stem cells (hiPSCs) to treat blindness. Her research bridges stem cell biology and bioengineering, tackling the critical bottleneck of scalable, clinical-grade cell production. In her landmark 2023 paper (30 citations), Dr. Bohrer outlines a fully automated workflow for generating autologous iPSCs, a foundational step toward enabling photoreceptor cell replacement therapy for inherited retinal degeneration—a leading cause of incurable vision loss. This work directly addresses the lack of commercial technologies for high-throughput parallel manufacturing, moving a once-theoretical treatment toward clinical reality. Complementing this, her 2023 study on automated hiPSC colony segmentation (10 citations) provides the machine vision and quality-control algorithms essential for reproducible, GMP-compliant cell culture. By integrating robotics, AI-driven image analysis, and stem cell biology, Dr. Bohrer is not just automating a process; she is building the manufacturing infrastructure for next-generation cell therapies. Her contributions are vital for students and researchers working at the intersection of automation and regenerative medicine, demonstrating how engineering solutions can unlock the therapeutic promise of stem cells.
Research Focus
Key Achievements
Top Papers
- 1
- 2